X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (176) 176
Publication (42) 42
Book / eBook (14) 14
Newspaper Article (4) 4
Book Review (3) 3
Book Chapter (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
index medicus (75) 75
male (72) 72
adult (60) 60
infectious diseases (50) 50
female (48) 48
middle aged (48) 48
hiv (37) 37
men (34) 34
human immunodeficiency virus--hiv (33) 33
immunology (31) 31
young adult (27) 27
article (26) 26
cancer (24) 24
prevalence (24) 24
sex (23) 23
homosexuality, male (21) 21
prevention (21) 21
aged (20) 20
human papillomavirus (20) 20
risk factors (20) 20
adolescent (19) 19
rectum (19) 19
aids/hiv (18) 18
infection (18) 18
sexual behavior (18) 18
research (17) 17
women (17) 17
biopsy (16) 16
health aspects (16) 16
hiv prevention (16) 16
public health (16) 16
risk (16) 16
safety (16) 16
tenofovir (16) 16
acceptability (15) 15
administration, rectal (15) 15
hiv infections - prevention & control (15) 15
public, environmental & occupational health (15) 15
human immunodeficiency virus (14) 14
papillomavirus infections - epidemiology (14) 14
hiv infections - complications (13) 13
infections (13) 13
microbiology (13) 13
sexually transmitted diseases (13) 13
acquired immune deficiency syndrome--aids (12) 12
papillomavirus infections (12) 12
virology (12) 12
aids (11) 11
analysis (11) 11
anti-hiv agents - administration & dosage (11) 11
gels (11) 11
hiv infection (11) 11
medicine (11) 11
microbicide (11) 11
microbicides (11) 11
msm (11) 11
preexposure prophylaxis (11) 11
prep (11) 11
research article (11) 11
risk-factors (11) 11
squamous intraepithelial lesions (11) 11
virus diseases (11) 11
anal intercourse (10) 10
mucosa (10) 10
multidisciplinary sciences (10) 10
age (9) 9
cohort studies (9) 9
dosage and administration (9) 9
epidemiology (9) 9
hiv infections - drug therapy (9) 9
law (9) 9
law and legislation (9) 9
papillomaviridae - isolation & purification (9) 9
prophylaxis (9) 9
science (9) 9
surveys and questionnaires (9) 9
active antiretroviral therapy (8) 8
cd4 antigen (8) 8
disease prevention (8) 8
great britain (8) 8
hiv-infection (8) 8
human-papillomavirus infection (8) 8
medicine & public health (8) 8
mens health (8) 8
natural-history (8) 8
pharmacokinetics (8) 8
social sciences, biomedical (8) 8
tenofovir - administration & dosage (8) 8
treatment outcome (8) 8
united states - epidemiology (8) 8
usage (8) 8
acquired immune deficiency syndrome (7) 7
administration, oral (7) 7
anal (7) 7
anal cancer (7) 7
anti-hiv agents - adverse effects (7) 7
anus neoplasms - pathology (7) 7
care and treatment (7) 7
clinical trials (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Veitenhansl, M and Stegner, K and Hierl, F.-X and Dieterle, C and Feldmeier, H and Gutt, B and Landgraf, R and Garrow, A P and Vileikyte, L and Findlow, A and Waterman, C and Boulton, A J. M and Shankhdhar, K and Shankhdhar, L and Shankhdhar, U and Petrova, N L and Foster, A V. M and Edmonds, M E and Ferraresi, R and Caravaggi, C and De Giglio, R and Cavaiani, P and Pogliaghi, I and Sommariva, E and Katz, I A and Harlan, A and Miranda-Palma, B and Prieto-Sanchez, L and Armstrong, D G and Bowker, J H and Mizel, M S and Cernea, S and Wohlgelernter, J and Kidron, M and Modi, P and Raz, I and Arbit, E and Nosek, L and Kapitza, C and Beckett, P and Gelfand, R and Goldberg, M and Heise, T and Testa, M A and Turner, R R and Hayes, J F and Scranton, R E and Simonson, D C and Yang, Y.-W and Hsu, Y.-J and Naujok, O and Francini, F and Jörns, A and Tiedge, M and Lenzen, S and Abdel-Wahab, Y H. A and Marenah, L and Orr, D F and Shaw, C and Flatt, P R and Chokkalingam, K and Mansell, P I and Clausen, P and Ekbom, P and Damm, P and Feldt-Rasmussen, U and Nielsen, B and Mathiesen, E R and Feldt-Rasmussen, B and Dewan, S and Da Silva, N and Ternan, P Mc and Leong, K S and Wilding, J P. H and Asatiani, N and Kurashvili, R and Dundua, M and Shelestova, E and Pagava, K and Ramazashvili, M and Hod, M and Smirnov, S and Petersen, J L. A and Justesen, T I and Ringholm Nielsen, L and Müller, C and Højlund, K and Wensaas, A and Kase, E T and Aas, V and Rustan, A C and Thoresen, G H and Levin, K and Beck-Nielsen, H and Gaster, M and Im, S.-S and Kang, S.-Y and Kim, S.-Y and Ahn, Y.-H and Lihn, A S and ... and The RECORD Study Group and AUDIT Investigators and DIABHYCAR Study Group and The FinnDiane Study Group and KANWU Study Group and FinnDiane Study Group and Spanish Group of MODY (GEM) and Fidarestat Study Group and HOE901/4009 Study Group and AT.LANTUS Study Group and Turkish Diabetes Centers Study Group and KORA Group and Group D.E.S.I.R and North West Adelaide Health Study Team and Euro Heart Survey Investigators and Belgian Diabetes Registry (Brussels, Belgium) and AT:LANTUS Study Group and Israel Diabetes Research Group (IDRG) and The ASDIAB Study Group and G. IMDIAB and 205-Nations Study Group and IMDIAB Group and EURODIAB PCS Group and Italian Repaglinide Study Group and DPV-Wiss-Study Group
Diabetologia, ISSN 0012-186X, 8/2004, Volume 47, Issue S1, pp. A1 - A464
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 07/2016, Volume 19, Issue 6 Suppl 5, pp. 21264 - n/a
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 01/2015, Volume 181, Issue 1, pp. 40 - 53
Journal Article
by M Veitenhansl and K Stegner and F-X Hierl and C Dieterle and H Feldmeier and B Gutt and R Landgraf and A P Garrow and L Vileikyte and A Findlow and C Waterman and A J M Boulton and K Shankhdhar and L Shankhdhar and U Shankhdhar and N L Petrova and A V M Foster and M E Edmonds and R Ferraresi and C Caravaggi and R De Giglio and P Cavaiani and I Pogliaghi and E Sommariva and I A Katz and A Harlan and B Miranda-Palma and L Prieto-Sanchez and D G Armstrong and J H Bowker and M S Mizel and S Cernea and J Wohlgelernter and M Kidron and P Modi and I Raz and E Arbit and L Nosek and C Kapitza and P Beckett and R Gelfand and M Goldberg and T Heise and M A Testa and R R Turner and J F Hayes and R E Scranton and D C Simonson and Y-W Yang and Y-J Hsu and O Naujok and F Francini and A Jörns and M Tiedge and S Lenzen and Y H A Abdel-Wahab and L Marenah and D F Orr and C Shaw and P R Flatt and K Chokkalingam and P I Mansell and P Clausen and P Ekbom and P Damm and U Feldt-Rasmussen and B Nielsen and E R Mathiesen and B Feldt-Rasmussen and S Dewan and N Da Silva and P Mc Ternan and K S Leong and J P H Wilding and N Asatiani and R Kurashvili and M Dundua and E Shelestova and K Pagava and M Ramazashvili and M Hod and S Smirnov and J L A Petersen and T I Justesen and L Ringholm Nielsen and C Müller and K Højlund and A Wensaas and E T Kase and V Aas and A C Rustan and G H Thoresen and K Levin and H Beck-Nielsen and M Gaster and S-S Im and S-Y Kang and S-Y Kim and Y-H Ahn and A S Lihn and ...
Diabetologia, ISSN 0012-186X, 08/2004, Volume 47, p. A1
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 01/2012, Volume 21, Issue 1, pp. 122 - 133
Journal Article
International and Comparative Law Quarterly, ISSN 0020-5893, 10/2010, Volume 59, Issue 4, pp. 1170 - 1171
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60147
Objective: Rectal microbicides are needed to reduce the risk of HIV acquisition associated with unprotected receptive anal intercourse. The MTN-007 study was... 
TRIALS | HIV-INFECTION | MICROBICIDE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | MEN | SEX | RISK | MODEL | ANAL INTERCOURSE | HIV Infections - prevention & control | Intestinal Mucosa - metabolism | Oligonucleotide Array Sequence Analysis | Rectum - pathology | Humans | Middle Aged | Administration, Rectal | Male | Intestinal Mucosa - drug effects | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | Rectum - drug effects | Adult | Female | Adenine - analogs & derivatives | Double-Blind Method | Gels | Anti-HIV Agents - adverse effects | Rectum - metabolism | Organophosphonates - adverse effects | Transcriptome - drug effects | Adenine - administration & dosage | Organophosphonates - administration & dosage | Dosage and administration | Safety and security measures | Flow cytometry | Mucosa | Cellulose | Microflora | Lymphocytes T | Acceptability | Prevention | Mens health | Randomization | Microbicides | Acquired immune deficiency syndrome--AIDS | Quality | Human immunodeficiency virus--HIV | Safety | Medical research | Health risks | Risk reduction | Histology | Inflammation | FDA approval | Gene expression | Nonoxynol | Inflammatory bowel disease | Birth control | Cytometry | Protein arrays | DNA microarrays | Rectum | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
by Veitenhansl, M and Stegner, K and Hierl, FX and Dieterle, C and Feldmeier, H and Gutt, B and Landgraf, R and Garrow, AP and Vileikyte, L and Findlow, A and Waterman, C and Boulton, AJ and Shankhdhar, K and Shankhdhar, L and Shankhdhar, U and Petrova, NL and Foster, AV and Edmonds, ME and Ferraresi, R and Caravaggi, C and De Giglio, R and Cavaiani, P and Pogliaghi, I and Sommariva, E and Katz, IA and Harlan, A and Miranda-Palma, B and Prieto-Sanchez, L and Armstrong, DG and Bowker, JH and Mizel, MS and Cernea, S and Wohlgelernter, J and Kidron, M and Modi, P and Raz, I and Arbit, E and Nosek, L and Kapitza, C and Beckett, P and Gelfand, R and Goldberg, M and Heise, T and Testa, MA and Turner, RR and Hayes, JF and Scranton, RE and Simonson, DC and Yang, YW and Hsu, YJ and Naujok, O and Francini, F and Jörns, A and Tiedge, M and Lenzen, S and Abdel-Wahab, YH and Marenah, L and Orr, DF and Shaw, C and Flatt, PR and Chokkalingam, K and Mansell, PI and Clausen, P and Ekbom, P and Damm, P and Feldt-Rasmussen, U and Nielsen, B and Mathiesen, ER and Feldt-Rasmussen, B and Dewan, S and Da Silva, N and Ternan, PM and Leong, KS and Wilding, JP and Asatiani, N and Kurashvili, R and Dundua, M and Shelestova, E and Pagava, K and Ramazashvili, M and Hod, M and Smirnov, S and Petersen, JL and Justesen, TI and Ringholm Nielsen, L and Müller, C and Højlund, K and Wensaas, A and Kase, ET and Aas, V and Rustan, AC and Thoresen, GH and Levin, K and Beck-Nielsen, H and Gaster, M and Im, SS and Kang, SY and Kim, SY and Ahn, YH and Lihn, AS and ...
Diabetologia, ISSN 1432-0428, 2004, Volume 47, Issue Suppl 1, p. A1
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e79492
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0126454
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0125363
Objectives The CHARM-01 study characterized the safety, acceptability, pharmacokinetics (PK), and pharmacodynamics (PD) of three tenofovir (TFV) gels for... 
TRIALS | AFRICAN WOMEN | ORAL TENOFOVIR | HIV-INFECTION | MICROBICIDE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | TISSUE | PREEXPOSURE PROPHYLAXIS | Anti-HIV Agents - pharmacology | T-Lymphocyte Subsets - immunology | Rectum - pathology | Humans | Middle Aged | Tenofovir - pharmacology | Anti-Infective Agents, Local - adverse effects | Male | Tenofovir - administration & dosage | Intestinal Mucosa - drug effects | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Microbiota | Intestinal Mucosa - immunology | T-Lymphocyte Subsets - drug effects | Adult | Female | Tenofovir - adverse effects | Gels | Anti-Infective Agents, Local - pharmacology | Anti-HIV Agents - adverse effects | HIV Infections - virology | Immunophenotyping | Treatment Outcome | Intestinal Mucosa - microbiology | Chemistry, Pharmaceutical | Medication Adherence | Phenotype | Anti-Infective Agents, Local - administration & dosage | T-Lymphocyte Subsets - metabolism | HIV Infections - drug therapy | Intestinal Mucosa - pathology | Tenofovir | Patient outcomes | Economic aspects | Dosage and administration | Research | Drug therapy | HIV infection | Formulations | Pharmacodynamics | Mucosa | Vagina | Infections | Pharmacology | Acceptability | Disease prevention | Medicine | Mens health | Randomization | Acquired immune deficiency syndrome--AIDS | Safety engineering | Human immunodeficiency virus--HIV | Rectum | Safety | Inhibition | Transgender persons | Pharmacokinetics | Drug dosages | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
American Journal of Public Health, ISSN 0090-0036, 09/2013, Volume 103, Issue 9, pp. e88 - e95
Journal Article